Indeed, OCT-4 together with SOX2 and NANOG is expressed in most if not all gliomas and their expression correlates with tumor aggressiveness with GBM cells showing greater nuclear staining for OCT-4 and SOX2 (104). The gene discussed is SOX2; the disease is central nervous system cancer.